This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1995 Oct;22(4 Pt 1):1326-9.

doi: 10.1016/0270-9139(95)90646-0.

Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C

H S Conjeevaram, J E Everhart, J H Hoofnagle

PMID: 7557888
DOI: 10.1016/0270-9139(95)90646-0

Review

Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C

H S Conjeevaram et al. Hepatology. 1995 Oct.

. 1995 Oct;22(4 Pt 1):1326-9.

doi: 10.1016/0270-9139(95)90646-0.

Authors

H S Conjeevaram, J E Everhart, J H Hoofnagle

PMID: 7557888
DOI: 10.1016/0270-9139(95)90646-0

No abstract available

PubMed Disclaimer

Similar articles

[Recombinant interferon alfa in the treatment of chronic hepatitis C].
Coelho HS, Soares JA, Carvalho BB, Santos MA, Soldan M. Coelho HS, et al. Rev Assoc Med Bras (1992). 1995 Sep-Oct;41(5):313-7. Rev Assoc Med Bras (1992). 1995. PMID: 8731593 Clinical Trial. Portuguese.
Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
Keeffe EB, Hollinger FB. Keeffe EB, et al. Hepatology. 1997 Sep;26(3 Suppl 1):101S-107S. doi: 10.1002/hep.510260718. Hepatology. 1997. PMID: 9305673 Review.
Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.
Camps J, Crisóstomo S, García-Granero M, Riezu-Boj JI, Civeira MP, Prieto J. Camps J, et al. Gut. 1993 Dec;34(12):1714-7. doi: 10.1136/gut.34.12.1714. Gut. 1993. PMID: 7904252 Free PMC article.
Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony-stimulating factor plus recombinant interferon-alpha.
Pardo M, Castillo I, Navas S, Carreño V. Pardo M, et al. J Med Virol. 1995 Apr;45(4):439-44. doi: 10.1002/jmv.1890450415. J Med Virol. 1995. PMID: 7545214 Clinical Trial.
Chronic hepatitis C. Advances in diagnostic testing and therapy.
Rubin RA, Falestiny M, Malet PF. Rubin RA, et al. Arch Intern Med. 1994 Feb 28;154(4):387-92. doi: 10.1001/archinte.154.4.387. Arch Intern Med. 1994. PMID: 7509593 Review.

See all similar articles

Cited by

Extracorporeal photopheresis alone and with interferon-alpha2a in chronic hepatitis C patients who failed previous interferon therapy.
O'Brien CB, Henzel BS, Moonka DK, Inverso J, Rook A. O'Brien CB, et al. Dig Dis Sci. 1999 May;44(5):1020-6. doi: 10.1023/a:1026677118006. Dig Dis Sci. 1999. PMID: 10235613 Clinical Trial.
Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations.
Pawlotsky JM, Germanidis G, Neumann AU, Pellerin M, Frainais PO, Dhumeaux D. Pawlotsky JM, et al. J Virol. 1998 Apr;72(4):2795-805. doi: 10.1128/JVI.72.4.2795-2805.1998. J Virol. 1998. PMID: 9525599 Free PMC article.
Determination of hepatitis C genotypes and the viral titer distribution in children and adolescents with major thalassemia.
Shahraki T, Shahraki M, Moghaddam ES, Najafi M, Bahari A. Shahraki T, et al. Iran J Pediatr. 2010 Mar;20(1):75-81. Iran J Pediatr. 2010. PMID: 23056686 Free PMC article.
[Characteristics of the hepatitis C virus and viral predictors of therapeutic response].
Ambrosch A, König W. Ambrosch A, et al. Med Klin (Munich). 1999 Nov 15;94(11):626-32. doi: 10.1007/BF03045003. Med Klin (Munich). 1999. PMID: 10603734 Review. German.
Viral hepatitis in elderly haemodialysis patients: current prevention and management strategies.
Girndt M. Girndt M. Drugs Aging. 2008;25(10):823-40. doi: 10.2165/00002512-200825100-00002. Drugs Aging. 2008. PMID: 18808207 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information